NetworkNewsBreaks – Software Effective Solutions
Post# of 161
(Total Views: 121)
Posted On: 07/12/2024 4:08:28 PM
NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) Ideally Positioned as DEA’s Move to Reclassify Cannabis Signals New Era
Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) noted a historic milestone as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. “The company released an announcement from CEO Jose Gabriel Diaz and observed that the ‘monumental decision,’ based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy… While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades. This was despite the fact that the substance has recognized medical benefits and low potential for abuse. The DEA’s shift to reschedule cannabis – a move that will now undergo a period of public comment – is a clear indication of its therapeutic value and aligns with evolving attitudes toward cannabis policy,” a recent article reads. “The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said Diaz. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana) noted a historic milestone as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. “The company released an announcement from CEO Jose Gabriel Diaz and observed that the ‘monumental decision,’ based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy… While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades. This was despite the fact that the substance has recognized medical benefits and low potential for abuse. The DEA’s shift to reschedule cannabis – a move that will now undergo a period of public comment – is a clear indication of its therapeutic value and aligns with evolving attitudes toward cannabis policy,” a recent article reads. “The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said Diaz. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”
NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://nnw.fm/SFWJ
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)